SDC3 and arthritic joint disease: In the first model (AIA), an intra-articular injection of soluble syndecan-3 significantly reduced overall histological parameters of disease as measured by an arthritis index in comparison with an intra-articular injection of PBS (P = 0.04: Fig. 3a–e).